Virofem & Viroscreen, of Weisbaden, Germany have entered into an agreement with bioTD to distribute Citofem® in Germany, Austria and Switzerland. The company is a major force in the European market for HPV detection, and will bring its knowledge and experience to Citofem distribution.
BioTD’s CEO Robin Wiscovitch commented, “Virofem & Viroscreen is a company we have admired for many years – a true leader in innovative and cost-effective approaches to in vitro diagnostics. We are thrilled to join forces and learn from them, as well as begin our efforts in critical and demanding European markets.”
© 2020 bioTD S.A. All Rights Reserved. Powered by